- Home
- MNTK vs IKT Comparison
MNTK vs IKT Comparison
Compare MNTK & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MNTK | IKT |
|---|---|---|
| Founded | 1980 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 202.0M | 240.1M |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MNTK | IKT |
|---|---|---|
| Price | $1.55 | $1.76 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $1.80 | ★ $5.00 |
| AVG Volume (30 Days) | 251.9K | ★ 722.6K |
| Earning Date | 05-07-2026 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 57.76 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $176,382,000.00 | N/A |
| Revenue This Year | $18.55 | N/A |
| Revenue Next Year | $12.68 | N/A |
| P/E Ratio | $146.00 | ★ N/A |
| Revenue Growth | ★ 0.37 | N/A |
| 52 Week Low | $1.07 | $1.33 |
| 52 Week High | $2.78 | $2.26 |
Technical Indicators
Market Signals| Indicator | MNTK | IKT |
|---|---|---|
| Relative Strength Index (RSI) | 57.56 | 45.93 |
| Support Level | $1.33 | $1.62 |
| Resistance Level | $1.57 | $1.90 |
| Average True Range (ATR) | 0.12 | 0.11 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 63.07 | 36.67 |
Price Performance
Historical ComparisonAbout MNTK Montauk Renewables Inc.
Montauk Renewables Inc is a renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments namely Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.